Fistulising Crohn’s disease - change or recommencement (treatment break less than 5 years) authority application form (PB236)

Use this form to apply to change or recommence PBS-subsidised treatment with a biological medicine for complex refractory fistulising Crohn’s disease, where recommencement is after a treatment break less than 5 years.

Biological medicine refers to adalimumab, infliximab and ustekinumab.

Please note: You don’t need to complete this form if you use the Online PBS Authorities system.

Download and complete the fistulising Crohn’s disease - change or recommencement (treatment break less than 5 years) authority application form.

Page last updated: 1 December 2025.
QC 45416